Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2022 Volume 24 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2022 Volume 24 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

The complement C3a‑C3aR and C5a‑C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF‑κB signaling

  • Authors:
    • Shasha Luo
    • Huiyan Xu
    • Xuechun Gong
    • Jinyan Shen
    • Xuan Chen
    • Zhifeng Wu
  • View Affiliations / Copyright

    Affiliations: Department of Ophthalmology, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, Jiangsu 214002, P.R. China, Department of Ophthalmology, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, Jiangsu 214002, P.R. China
    Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 493
    |
    Published online on: June 7, 2022
       https://doi.org/10.3892/etm.2022.11420
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Retinal detachment (RD) and its special form of rhegmatogenous RD associated with choroidal detachment (RRDCD) feature similar pathological alterations, including enhanced retinal cell inflammation. Although the importance of the complement components C3a and C5a and their corresponding receptors in retinal maintenance has been demonstrated, the relevance of these molecules to the pathogenesis of RD or RRDCD remains to be investigated. The contents of C3a, C5a and inflammatory factors, such as TNF‑α, IL‑1β, IL‑6 and prostaglandin (PG)E2, in related clinical samples were examined by ELISA. Subsequently, human retinal pigment epithelial (HRPE) cells were subjected to challenge with the C3a and C5a recombinant proteins with or without C3a and C5a antagonists and NF‑κB inhibitor, and the cell viability and inflammatory cytokines were then determined by a Cell Counting Kit‑8 assay and ELISA, respectively. In addition, reverse transcription‑quantitative PCR and western blot analyses were utilized to examine the mRNA or/and protein levels of C3a and its receptor C3aR, as well as C5a and its receptor C5aR, and NF‑κB. In addition, the correlation of C3a and C5a with the aforementioned inflammatory factors was analyzed. The inflammatory factor levels of C3a and C5a were considerably elevated in patients with RRDCD compared to those in the controls. Consistently, C3a and C5a treatment led to increased cell viability and aggravated inflammation in HRPE cells. Accordingly, C3a and C5a induced upregulation of their corresponding receptors C3aR and C5aR, which was in turn observed to be linked to the activation of the NF‑κB signaling pathway. Furthermore, there was a positive correlation of the complements C3a and C5a with individual TNF‑α, IL‑1β, IL‑6 and PGE2. Taken together, the C3a‑C3aR and C5a‑C5aR pathways were indicated to promote cell viability and inflammation of HRPE cells by targeting the NF‑κB signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Leach LL and Clegg DO: Concise review: Making stem cells retinal: Methods for deriving retinal pigment epithelium and implications for patients with ocular disease. Stem Cells. 33:2363–2373. 2015.PubMed/NCBI View Article : Google Scholar

2 

Xu H, Lutrin D and Wu Z: Outcomes of 23-gauge pars plana vitrectomy combined with phacoemulsification and capsulotomy without intraocular lens implantation in rhegmatogenous retinal detachment associated with choroidal detachment. Medicine (Baltimore). 96(e7869)2017.PubMed/NCBI View Article : Google Scholar

3 

Xu C, Wu J and Feng C: Changes in the postoperative foveal avascular zone in patients with rhegmatogenous retinal detachment associated with choroidal detachment. Int Ophthalmol. 40:2535–2543. 2020.PubMed/NCBI View Article : Google Scholar

4 

Wu Z, Ding N, Yu M, Wang K, Luo S, Zou W, Zhou Y, Yan B and Jiang Q: Identification of potential biomarkers for rhegmatogenous retinal detachment associated with choroidal detachment by vitreous iTRAQ-based proteomic profiling. Int J Mol Sci. 17(2052)2016.PubMed/NCBI View Article : Google Scholar

5 

Klettner A and Roider J: Retinal pigment epithelium expressed toll-like receptors and their potential role in age-related macular degeneration. Int J Mol Sci. 22(8387)2021.PubMed/NCBI View Article : Google Scholar

6 

Al-Nawaiseh S, Thieltges F, Liu Z, Strack C, Brinken R, Braun N, Wolschendorf M, Maminishkis A, Eter N and Stanzel BV: A step by step protocol for subretinal surgery in rabbits. J Vis Exp. (53927)2016.PubMed/NCBI View Article : Google Scholar

7 

Dai Y, Wu Z, Sheng H, Zhang Z, Yu M and Zhang Q: Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment. Mol Vis. 21:417–427. 2015.PubMed/NCBI

8 

Strauss O: The retinal pigment epithelium in visual function. Physiol Rev. 85:845–881. 2005.PubMed/NCBI View Article : Google Scholar

9 

Yu M, Zou W, Peachey NS, McIntyre TM and Liu J: A novel role of complement in retinal degeneration. Invest Ophthalmol Vis Sci. 53:7684–7692. 2012.PubMed/NCBI View Article : Google Scholar

10 

Ao J, Wood JP, Chidlow G, Gillies MC and Casson RJ: Retinal pigment epithelium in the pathogenesis of age-related macular degeneration and photobiomodulation as a potential therapy? Clin Exp Ophthalmol. 46:670–686. 2018.PubMed/NCBI View Article : Google Scholar

11 

Luo S, Chen Y, Yang L, Gong X and Wu Z: The complement system in retinal detachment with choroidal detachment. Curr Eye Res. 1–14. 2022.PubMed/NCBI View Article : Google Scholar : (Epub ahead of print).

12 

Wang J, Wang Y, Yu D, Liu Q, Lin S, Tian R, Li J and Luo Y: Protective effect of a bispecific Fc-fusion protein on the barrier of human retinal pigment epithelial cells. Ophthalmic Res. 64:656–663. 2021.PubMed/NCBI View Article : Google Scholar

13 

Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008.PubMed/NCBI View Article : Google Scholar

14 

Hollborn M, Ackmann C, Kuhrt H, Doktor F, Kohen L, Wiedemann P and Bringmann A: Osmotic and hypoxic induction of the complement factor C9 in cultured human retinal pigment epithelial cells: Regulation of VEGF and NLRP3 expression. Mol Vis. 24:518–535. 2018.PubMed/NCBI

15 

Busch C, Annamalai B, Abdusalamova K, Reichhart N, Huber C, Lin Y, Jo EAH, Zipfel PF, Skerka C, Wildner G, et al: Anaphylatoxins activate Ca2+, Akt/PI3-kinase, and FOXO1/FoxP3 in the retinal pigment epithelium. Front Immunol. 8(703)2017.PubMed/NCBI View Article : Google Scholar

16 

Song D, Ueda Y, Bhuyan R, Mohammed I, Miwa T, Gullipali D, Kim H, Zhou L, Song Y, Schultz H, et al: Complement factor H mutation W1206R causes retinal thrombosis and ischemic retinopathy in mice. Am J Pathol. 189:826–838. 2019.PubMed/NCBI View Article : Google Scholar

17 

Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, Lim YS, Whitfeld PL, Craig S, Corsini E, Lu B, et al: The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem. 285:7633–7644. 2010.PubMed/NCBI View Article : Google Scholar

18 

Thurman JM, Lenderink AM, Royer PA, Coleman KE, Zhou J, Lambris JD, Nemenoff RA, Quigg RJ and Holers VM: C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. J Immunol. 178:1819–1828. 2007.PubMed/NCBI View Article : Google Scholar

19 

Ahamed J, Venkatesha RT, Thangam EB and Ali H: C3a enhances nerve growth factor-induced NFAT activation and chemokine production in a human mast cell line, HMC-1. J Immunol. 172:6961–6968. 2004.PubMed/NCBI View Article : Google Scholar

20 

Martin CB, Ingersoll SA and Martin BK: Transcriptional control of the C3a receptor gene in glial cells: Dependence upon AP-1 but not Ets. Mol Immunol. 44:703–712. 2007.PubMed/NCBI View Article : Google Scholar

21 

Jo DH, Cho CS and Kim JH and Kim JH: Intracellular amyloid-β disrupts tight junctions of the retinal pigment epithelium via NF-κB activation. Neurobiol Aging. 95:115–122. 2020.PubMed/NCBI View Article : Google Scholar

22 

Feng Q, Yang W, Gao Z, Ruan X and Zhang Y: Up-regulation of P-gp via NF-κB activation confers protection against oxidative damage in the retinal pigment epithelium cells. Exp Eye Res. 181:367–373. 2019.PubMed/NCBI View Article : Google Scholar

23 

Hu Y, Lin H, Dib B, Atik A, Bouzika P, Lin C, Yan Y, Tang S, Miller JW and Vavvas DG: Cholesterol crystals induce inflammatory cytokines expression in a human retinal pigment epithelium cell line by activating the NF-κB pathway. Discov Med. 18:7–14. 2014.PubMed/NCBI

24 

Armento A, Schmidt TL, Sonntag I, Merle DA, Jarboui MA, Kilger E, Clark SJ and Ueffing M: CFH loss in human RPE cells leads to inflammation and complement system dysregulation via the NF-κB pathway. Int J Mol Sci. 22(8727)2021.PubMed/NCBI View Article : Google Scholar

25 

Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS and Michels RM: An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 112:159–165. 1991.PubMed/NCBI View Article : Google Scholar

26 

Bröker K, Terzenbach R, Bentzien F, Lüth S and Dammermann W: Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity. J Transl Med. 17(6)2019.PubMed/NCBI View Article : Google Scholar

27 

Huang Y, Enzmann V and Ildstad ST: Stem cell-based therapeutic applications in retinal degenerative diseases. Stem Cell Rev Rep. 7:434–445. 2011.PubMed/NCBI View Article : Google Scholar

28 

Murakami Y, Notomi S, Hisatomi T, Nakazawa T, Ishibashi T, Miller JW and Vavvas DG: Photoreceptor cell death and rescue in retinal detachment and degenerations. Prog Retin Eye Res. 37:114–140. 2013.PubMed/NCBI View Article : Google Scholar

29 

Strainic MG, Liu J, Huang D, An F, Lalli PN, Muqim N, Shapiro VS, Dubyak GR, Heeger PS and Medof ME: Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity. 28:425–435. 2008.PubMed/NCBI View Article : Google Scholar

30 

Ricklin D, Hajishengallis G, Yang K and Lambris JD: Complement: A key system for immune surveillance and homeostasis. Nat Immunol. 11:785–797. 2010.PubMed/NCBI View Article : Google Scholar

31 

Wu KY, Zhang T, Zhao GX, Ma N, Zhao SJ, Wang N, Wang JX, Li ZF, Zhou W and Li K: The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice. Kidney Int. 96:612–627. 2019.PubMed/NCBI View Article : Google Scholar

32 

Luo JL, Kamata H and Karin M: IKK/NF-kappaB signaling: Balancing life and death-a new approach to cancer therapy. J Clin Invest. 115:2625–2632. 2005.PubMed/NCBI View Article : Google Scholar

33 

Sun SC and Liu ZG: A special issue on NF-κB signaling and function. Cell Res. 21:1–2. 2011.PubMed/NCBI View Article : Google Scholar

34 

Liu T, Zhang L, Joo D and Sun SC: NF-κB signaling in inflammation. Signal Transduct Target Ther. 2(17023)2017.PubMed/NCBI View Article : Google Scholar

35 

Ling J and He P: miR-361-5p regulates ovarian cancer cell proliferation and apoptosis by targeting TRAF3. Exp Ther Med. 21(199)2021.PubMed/NCBI View Article : Google Scholar

36 

Liu Y, Wang K, Liang X, Li Y, Zhang Y, Zhang C, Wei H, Luo R, Ge S and Xu G: Complement C3 produced by macrophages promotes renal fibrosis via IL-17A secretion. Front Immunol. 9(2385)2018.PubMed/NCBI View Article : Google Scholar

37 

Dewan SMR, Osaka M, Deushi M and Yoshida M: Complement C5a-triggered differentiated HL-60 stimulates migration of THP-1 monocytic leukocytes via secretion of CCL2. FEBS Open Bio. 11:1374–1381. 2021.PubMed/NCBI View Article : Google Scholar

38 

Luo C, Zhao J, Chen M and Xu H: The expression of C1 inhibitor (C1INH) in macrophages is upregulated by retinal pigment epithelial cells-implication in subretinal immune privilege in the aging eye. Aging (Albany NY). 10:1380–1389. 2018.PubMed/NCBI View Article : Google Scholar

39 

Zhao Q, Ji M and Wang X: IL-10 inhibits retinal pigment epithelium cell proliferation and migration through regulation of VEGF in rhegmatogenous retinal detachment. Mol Med Rep. 17:7301–7306. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Luo S, Xu H, Gong X, Shen J, Chen X and Wu Z: The complement C3a‑C3aR and C5a‑C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF‑κB signaling. Exp Ther Med 24: 493, 2022.
APA
Luo, S., Xu, H., Gong, X., Shen, J., Chen, X., & Wu, Z. (2022). The complement C3a‑C3aR and C5a‑C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF‑κB signaling. Experimental and Therapeutic Medicine, 24, 493. https://doi.org/10.3892/etm.2022.11420
MLA
Luo, S., Xu, H., Gong, X., Shen, J., Chen, X., Wu, Z."The complement C3a‑C3aR and C5a‑C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF‑κB signaling". Experimental and Therapeutic Medicine 24.2 (2022): 493.
Chicago
Luo, S., Xu, H., Gong, X., Shen, J., Chen, X., Wu, Z."The complement C3a‑C3aR and C5a‑C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF‑κB signaling". Experimental and Therapeutic Medicine 24, no. 2 (2022): 493. https://doi.org/10.3892/etm.2022.11420
Copy and paste a formatted citation
x
Spandidos Publications style
Luo S, Xu H, Gong X, Shen J, Chen X and Wu Z: The complement C3a‑C3aR and C5a‑C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF‑κB signaling. Exp Ther Med 24: 493, 2022.
APA
Luo, S., Xu, H., Gong, X., Shen, J., Chen, X., & Wu, Z. (2022). The complement C3a‑C3aR and C5a‑C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF‑κB signaling. Experimental and Therapeutic Medicine, 24, 493. https://doi.org/10.3892/etm.2022.11420
MLA
Luo, S., Xu, H., Gong, X., Shen, J., Chen, X., Wu, Z."The complement C3a‑C3aR and C5a‑C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF‑κB signaling". Experimental and Therapeutic Medicine 24.2 (2022): 493.
Chicago
Luo, S., Xu, H., Gong, X., Shen, J., Chen, X., Wu, Z."The complement C3a‑C3aR and C5a‑C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF‑κB signaling". Experimental and Therapeutic Medicine 24, no. 2 (2022): 493. https://doi.org/10.3892/etm.2022.11420
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team